Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169273 · ClinicalTrials.gov registry record · NA
Epidemiology and Care of Comorbid Obesity and Depression
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT00169273: Completed NA study, sponsored by Kaiser Permanente.
NCT00169273 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169273, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
We propose to: * Conduct cross-sectional assessments of depression, disability, health-related quality of life, eating patterns, and eating attitudes in a population-based sample approximately 6000 women aged 40-60 with over-sampling of women with BMI greater than 30 kg/m2. * Among obese women free of depression, enroll approximately 100 in a 6-month standard behavior therapy weight management program. * Among obese women with significant depression, randomly assign 200 to either a 6-month standard behavior therapy weight management program or a combined cognitive-behavior therapy program focused on both depression and weight management. * Complete follow up assessments of weight, depressive symptoms, and functional status in all three treatment groups for 12 months following enrollment Screening and follow-up data will be used to address the following questions: * Association between depression and obesity among middle-aged women * Specific effects of depression and obesity on functional status, disability, and health services utilization * Impact of depression on participation in and outcomes of a standardized weight management program * Benefit of combined treatment (focused on depression and weight management) above that of standardized behavioral therapy for obese women with significant depressive symptoms.
Interventions
- BEHAVIORAL Structured behavioral weight loss group
- BEHAVIORAL Weight loss and cognitive-behavioral depression group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-04 |
| Phase | NA |
What the finished NCT00169273 record still lists
NCT00169273 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Structured behavioral weight loss group is the first listed.
NCT00169273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00169273 about?
NCT00169273 is a clinical study titled "Epidemiology and Care of Comorbid Obesity and Depression". We propose to: * Conduct cross-sectional assessments of depression, disability, health-related quality of life, eating patterns, and eating attitudes in a population-based sample approximately 6000 women aged 40-60 with over-sampling of women with BMI greater than 30 kg/m2. * Among obese women free...
What is the current status of trial NCT00169273?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2004-04. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00169273?
The interventions under investigation include: Structured behavioral weight loss group (BEHAVIORAL), Weight loss and cognitive-behavioral depression group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00169273?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00169273's enrollment target sits among peer trials
192 570th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia